⌘K

Login Start Free

Home/Filings/4/0001493152-21-020787

4//SEC Filing

Kruger Kurt H 4

Accession 0001493152-21-020787

CIK 0001460702other

View on SEC.gov Company Profile

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 3:05 PM ET

Size

6.0 KB

Accession

0001493152-21-020787

Insider Transaction Report

Form 4

Period: 2021-08-19

Qualigen Therapeutics, Inc.QLGN

Director

Transactions

Purchase
Common Stock
2021-08-19$1.22/sh+4,000$4,880→ 18,000 total
Purchase
Common Stock
2021-08-19$1.23/sh+4,000$4,920→ 14,000 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Qualigen Therapeutics, Inc.

CIK 0001460702

Entity typeother

Related Parties

1

filerCIK 0001375881

Filing Metadata

Form type: 4
Filed: Aug 19, 8:00 PM ET
Accepted: Aug 20, 3:05 PM ET
Size: 6.0 KB

View on SEC.gov